Home Journals Articles Updates About
CN
image
收藏切换
Causality assessment strategies and methods for Chinese medicines-induced liver injury
收藏切换
PDF
Jia-bo WANG1, Le ZHANG1, Yu-ming GUO1, Zhao-fang BAI1, Xiao-he XIAO2, *
Acta Pharmaceutica Sinica | 2018, 53(6) : 920 - 928
Less
收藏切换
Acta Pharmaceutica Sinica | 2018, 53(6): 920-928
• REVIEWS •
Causality assessment strategies and methods for Chinese medicines-induced liver injury
Full
Jia-bo WANG1, Le ZHANG1, Yu-ming GUO1, Zhao-fang BAI1, Xiao-he XIAO2, *
Affiliations
  • 1. China Military Institute of Chinese Medicines, 302 Military Hospital of China, Beijing 100039, China
  • 2. Integrative Medicine Center, 302 Military Hospital of China, Beijing 100039, China
Published: 2018-06-12 doi: 10.16438/j.0513-4870.2018-0439
Outline
收藏切换

Chinese medicines (CM)-induced liver injury is one of the severe adverse drug reactions (ADRs) in clinical application, which restricts new drug research and development (R&D), clinical safe usage and industry development of CM. The issue, to elucidate the causality between liver injury and CM, is either a globally challenging problem or the precondition of CM safety evaluation. However, owing to the complexicity of CM and various influencing factors to CM-induced liver injury, the causality assessment for CM is much difficult, compared to synthetic drugs. Besides, the current assessment methods, primarily designed for clinical diagnosis, are difficult to be used in new drug R&D of CM. Hereinto, we reviewed the current ADR causality methods and proposed a new strategy called integrated evidence chain-based causality assessment method for CM-induced liver injury. The new causality method is designed for new drug R&D based on the complexicity of CM, to provide methodology in scientific assessment of causality of CM-induced liver injury and to promote success rate of new drug R&D. The new method could also raise our ability to find, avoid and prevent the risk of CM-induced liver injury.

Chinese medicines  /  drug-induced liver injury  /  causality assessment  /  integrated evidence chain
Jia-bo WANG, Le ZHANG, Yu-ming GUO, Zhao-fang BAI, Xiao-he XIAO. Causality assessment strategies and methods for Chinese medicines-induced liver injury[J]. Acta Pharmaceutica Sinica, 2018 , 53 (6) : 920 -928 . DOI: 10.16438/j.0513-4870.2018-0439
Appendix
Less
Year 2018 volume 53 Issue 6
PDF
127
49
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2018-0439
  • Receive Date：2018-05-14
  • Online Date：2026-01-15
  • Published：2018-06-12
Article Data
Affiliations
History
  • Received：2018-05-14
  • Revised：2018-05-21
Funding
Affiliations
    1. China Military Institute of Chinese Medicines, 302 Military Hospital of China, Beijing 100039, China
    2. Integrative Medicine Center, 302 Military Hospital of China, Beijing 100039, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2018-0439
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House